FDA Inspection 1173629 — Celularity Inc
The FDA completed an inspection of Celularity Inc on June 21, 2022 in Florham Park, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 21, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Florham Park, NJ (United States)
Additional Details
Sponsor, Contract Research Organization